Mackenzie Financial Corp Raises Position in DexCom, Inc. $DXCM

NodeGuardian · 2026-03-15T15:23:04+00:00

Mackenzie Financial Corp increased its DexCom stake by over 87,000 shares, totaling 1.1 million shares valued at $74.4 million. Other investors also raised positions as DexCom received positive analyst ratings and outperformed competitors.

NodeGuardian

2026-03-15 15:23:04

Abstract generation in progress

Mackenzie Financial Corp significantly increased its stake in DexCom, Inc. during the third quarter, purchasing an additional 87,623 shares and bringing its total ownership to over 1.1 million shares valued at approximately $74.4 million. Other institutional investors like Marshall Wace LLP, E. Ohman J or Asset Management AB, Zevenbergen Capital Investments LLC, Mirae Asset Global Investments Co. Ltd., and NEOS Investment Management LLC also raised their positions in the medical device company. DexCom has received positive analyst sentiment with several “buy” ratings and price target increases, and outperformed competitors despite broader market losses.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes